Team:Bielefeld-Germany/Results/vector

From 2012.igem.org

(Difference between revisions)
(Description of the shuttle vector system)
(Description of the shuttle vector system)
Line 45: Line 45:
|-
|-
|Kozak sequence
|Kozak sequence
-
|[http://partsregistry.org/Part:BBa_J63003 BBa_J63003]
+
|[http://partsregistry.org/Part:BBa_J63003 J63003]
|[http://partsregistry.org/wiki/index.php?title=Part:BBa_J63003 BBa_J63003]
|[http://partsregistry.org/wiki/index.php?title=Part:BBa_J63003 BBa_J63003]
|integrated in primer sequence
|integrated in primer sequence

Revision as of 01:47, 27 September 2012

Summary

Contents


Description of the shuttle vector system

The design of a minimal shuttle vector system with defined regions (or better DNA fragments) for expression and secretion of proteins of interest (POI), like laccase, which needed glycolisation is the basic concept. The shuttle vector needs a bacterial part for cloning in bacteria (like E. coli) and an eucaryotic part for genomic integration and selection in yeast (like P. pastoris). An other team will be able to clime in frame their gene of interest via the AarI restriction site. With only one restriction ligation cloning step the shuttle vector will be ready to use and integrate in the eucaryote P. pastoris.

The shuttle vector consists of the plasmid pSB1C3, 5' UTR of alcohol oxidase 1 gene (aox1) containing the aox1 promoter region, Kozak sequence, mating factor alpha 1 (MFalpha1), AarI restriction site, aox1 terminator, his4 gene and 3' UTR of aox1 gene. Cloning and plasmid replication in E. coli are able via the pSB1C3 part. The gene of interest (like laccase) can be included in frame with MFalpha1 via AarI restriction site. With the N-terminal MFalpha1 the POI could be secreted in the media. Genomic integation of MFalpha1-taged POI is able via the 5' UTR and 3' UTR of the aox1 gene. This allows a double cross over and the genomic integration without any bacterial proportion of DNA which could be a decisive point for industrial application. The complementation of histidine auxotrophie via his4 gene was chosen instead of a zeocine resistance. This selection strategy is chosen because we want to avoid the application of antibiotics.

Gibson assembly was used for building the shuttle vector (see the figure below) and the fragments with 5' overlap were amplified via PCR. In addition, the fragments were designed as basic BioBrick parts for different applications by the community. The origin of the DNA sequence for design of the shuttle vector and the source of DNA for PCR is listed in the table below.

Elements of the shuttle vector and their origin

Element BioBrick Origin of DNA sequence of design Origin of DNA sequence of PCR
pSB1C3 pSB1C3 pSB1C3 pSB1C3
5'UTR of aox1 K863200 plasmid pPICZalphaA (Invitrogen) P. pastoris wild type X-33
Kozak sequence J63003 BBa_J63003 integrated in primer sequence
MFalpha1 K863206 plasmid pPICZalphaA (Invitrogen) plasmid pPICZalphaA (Invitrogen)
aox1 terminater K863203 plasmid pPIC9K P. pastoris wild type X-33
his4 K863202 plasmid pPIC9K P. pastoris wild type X-33
3'UTR of aox1 K863201 plasmid pPIC9K P. pastoris wild type X-33


Plasmid map from shuttle vector pSB1C3::BBa_K863204.

Shuttle vector in E. coli

The developed shuttle vector could transformed in E. coli and analyzed by restriction with the enzymes PvuII and HindIII. The restriction pattern is positiv. A sequencing was also done.

Shuttle vector in P. pastoris

After linearization by restriction with EcoRI and SpeI the shuttle vector could be transformed in competent P. pastoris cells. On selective media plates for complementation of histidine auxotrophy some transformants growth (see the picture below). For differentiation between the M+ and Ms genotype a PCR with the Primer 5AOX-Genotyp-FW and TT-Genotyp-RV was done.

GFP integrated in shuttle vector

Cloning of green fluorescent protein (GFP) via the AarI restriction site into the shuttle vector was done for testing the system. A restriction analyze with enzymes ans a sequencing could not be done. The next steps will be (a) linearization with EcoRI and SpeI restriction enzymes, (b) transformation in competent P. pastoris cells, (c) genotype characterization by PCR with 5AOX-Genotype-FW and TT-Genotype-RV primers, (d) cultivation with methanol induction for GFP production and at last (e) fluorescence measure of the cultivation broth.


55px Logo merck.jpg BioCircle.JPG Bielefeld2012 Evonik.jpg Bielefeld2012 Baxter.png Logo knauer.jpg Logo iit.jpg Bielefeld2012 BIEKUBA.jpg Logo biometra.jpg Logo bio-nrw.png Bielefeld2012 Logo ERASynbio.jpg